Circulating tumour cells (CTCs) are rare tumor cells that have been investigated for diagnostic, prognosis and predictive biomarkers for different types of cancer. CTCs have been described back in 1869….
Continue readingCircular RNAs (circRNAs) are class of long, non-coding RNAs, which are very tissue specific. Initially these circRNAs were thought to have no biological function. In the recent research there are…
Continue readingCancer immunotherapy is a promising field in drug development because it provides new treatment options for various cancers, especially in combination with standard of care. Immune system can recognize and…
Continue readingMicroRNAs (miRNAs) are non-coding RNAs, which are used generally to down-regulate gene expression from messenger RNA (mRNA) by binding to it. miRNAs are getting popular in potential application in cancer…
Continue readingAccording to estimates in US approximately 6 – 14% of newly diagnosed patients will develop brain metastases. Almost 45% of patients with lung cancer will develop brain metastases, based on…
Continue readingGene editing techniques are exciting for scientist and oncologists who hope that they will give a new approach in treating cancer and even opportunity to eradicate it all. The idea…
Continue readingWhile the classic chemotherapy agents are cytotoxics, which do not have specific target, the new approach in oncology drug development is focused on immunotherapy, where the new compounds target specific…
Continue readingPrecision Medicine is getting very popular in terms of the future of medicine and managing the rising costs of treatment. Maybe one of the most expensive therapeutic areas at the…
Continue readingWe often hear on the news that a new promising oncology treatment is developed but later on that it was not successful. What are the challenges in drug development in…
Continue readingMajority of the clinical trials require images to be performed and often sent to external vendor. These imaging requirements vary between different clinical trials and information about specifications should be…
Continue reading